key: cord-0935612-mm9qzato
authors: Mojoli, Francesco; Cutti, Sara; Mongodi, Silvia; Bruno, Raffaele; Di Sabatino, Antonio; Corsico, Angelo Guido; Marena, Carlo
title: The potential role of ICU capacity strain in COVID-19 mortality: comparison between first and second waves in Pavia, Italy
date: 2021-10-22
journal: J Anesth Analg Crit Care
DOI: 10.1186/s44158-021-00007-6
sha: d396dcc5bac9ff7af74625c291ba60811d4228a6
doc_id: 935612
cord_uid: mm9qzato

nan

In novel coronavirus disease (COVID-19) pandemic, a high mortality rate was reported during wave 1, particularly when COVID-19 load exceeded 100% ICU capacity [1] . With better knowledge of the disease [2, 3] , a lower mortality was expected in wave 2; however, similar mortalities were reported for hospital/ICU populations [4] . Within the same wave, in-hospital mortality was lower once past the peak of hospital affluence [1, 5] , suggesting a role of ICU facilities' availability. However, their actual role remains unclear since mortality was high also in non-overwhelmed healthcare systems [6] .

To test if disproportion between ICU facilities and hospitalized patients impact COVID-19 mortality, we compared the first 8 weeks of waves 1 vs. 2 in Pavia (Lombardy, Italy). ICU-timing (time from hospital to ICU admission), percentage of COVID-19 hospitalized patients admitted to ICU, and percentage of intubated patients in ICU were considered ICU capacity strain's markers. All patients during wave 2 received steroids as appropriate [3] . Local ethic committee approved the study.

Patients' characteristics are in Table 1 . In wave 1, a steep increase of ICU COVID-19 patients reached a peak of 64 on day 34 (Fig. 1A) ; a plateau phase lasted 14/56 days (25.0%); thereafter, a reduction was observed. In wave 2 (Fig. 1B) , a slower increase achieved a lower peak (54 patients) on day 40 and lasted 4/56 days (7.1%; p=0.010).

At day 56 of wave 1, patients admitted to ICU were 139, ICU mortality was 54/84 (64.3%), patients still in ICU were 55 (39.6%), and their follow-up ICU mortality was 14/55 (25.5%), lower than in the beginning of the same wave (p<0.0001).

At day 56 of wave 2, patients admitted to ICU were 119, ICU mortality was 18/74 (24.3%; p<0.0001 vs. wave 1), patients still in ICU were 45 (37.8%), and their follow-up ICU mortality was 16/45 (35.6%), similar to the first 8 weeks (p=0.2133). Findings in ward patients are displayed in Fig. 1C , D.

In waves 1 and 2, hospital mortality was in overall ICU patients 48.9% and 30.3% (p=0.0033), in intubated patients 50.7 and 36.7% (p=0.0410), in ward patients 33.3% and 19.6% (p<0.0001), respectively.

Wave 2 determined a lower ICU strain: patients that could be treated in ICU were 17.7 vs. 13.1% (relative increase 35.1%; p=0.0104); ICU-timing was shorter (57±92 vs. 90±91 h; p=0.0047), with patients admitted to ICU within 48 h 58.0 vs. 40.3% (p=0.0059); and intubation was less frequent (75.6 vs. 96.4%; p<0.0001).

ICU-timing was resulted in an independent risk factor for hospital mortality when adjusted for age, gender, and need of invasive ventilation (p<0.0001).

The improvement of ICU and ward patients' outcome exceeded what expected from steroids' introduction [3] , supporting that other factor may have a role [5] . ICU strain was significantly higher during wave 1. Moreover, patients were admitted to ICU later, when intubation Fig. 1 The first 8 weeks of the two pandemic waves in ICU and in the wards: this timeframe was representative of the critical phase for our healthcare system, including rapid increase of ICU patients up to a peak (red arrows), plateau phase, and initial decline (green arrows). A Wave 1 in ICU. A steep increase of ICU COVID-19 patients was observed until a peak of 64; pre-pandemic capacity was 32 beds. The peak was reached on day 34; a plateau phase persisted until day 48; thereafter, a reduction was observed. was almost unavoidable, which may increase mortality [5] . ICU-timing was an independent predictor of mortality, suggesting intensive care should be considered a time-dependent treatment for COVID-19 patients.

In conclusion, COVID-19 mortality notably decreased in wave 2 at our institution; beyond the benefits of a deeper knowledge of the disease, lower ICU capacity strain and timelier ICU admission may have played a role.

Abbreviations COVID-19: Novel coronavirus disease; ICU: Intensive care unit

Association of intensive care unit patient load and demand with mortality rates in US Department of Veterans Affairs Hospitals during the COVID-19 pandemic

Outcomes of COVID-19 patients treated with continuous positive airway pressure outside the intensive care unit

Dexamethasone in Hospitalized Patients with Covid-19

Comparison between first and second wave among critically ill COVID-19 patients admitted to a French ICU: no prognostic improvement during the second wave?

Changes in in-hospital mortality in the first wave of COVID-19: a multicentre prospective observational cohort study using the WHO Clinical Characterisation Protocol UK

Case characteristics, resource use, and outcomes of 10 021 patients with COVID-19 admitted to 920 German hospitals: an observational study

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations

Authors' contributions FM conceived the research protocol, collected and analysed the data, wrote the draft, and revised it critically before submission. SC collected and analysed the data and revised the draft critically before submission. SM collected and analysed the data, wrote the draft, and revised it critically before submission. RB collected the data and revised the draft critically before submission. AGC collected the data and revised the draft critically before submission. All authors read and approved the final manuscript.

Availability of data and materials The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.

Ethics approval and consent to participate The study was approved by local ethic committee.

All the patients signed an informed consent for data publication.